首页 | 本学科首页   官方微博 | 高级检索  
     检索      

生物技术药物发展迅猛,突破性疗法认证推动药物创新——2017年新药研发热点回眸
引用本文:李子艳,黄瑶庆,周映红,毛艳艳,高柳滨.生物技术药物发展迅猛,突破性疗法认证推动药物创新——2017年新药研发热点回眸[J].科技导报(北京),2018,36(1):116-125.
作者姓名:李子艳  黄瑶庆  周映红  毛艳艳  高柳滨
作者单位:中国科学院上海药物研究所信息中心, 上海 201203
基金项目:中国科学院A类战略性先导科技专项(XDA12050201)
摘    要: 新药研发集中体现生命科学和生物技术领域的新突破和新进展。当前,药物研发相关学科交叉日趋紧密,新方法、新技术层出不穷,在提升药物研发效率的同时快速革新疾病的治疗手段。从2017年美国食品药品监督管理局(FDA)批准的新药来看,生物技术药物发展异常迅猛,突破性疗法认证推动药物创新,临床上未满足的需求成为行业的追求目标。本文回顾2017年新药研发领域的突破性进展和研发热点,展示新药研发新趋势和新动向。

关 键 词:新药研发  肿瘤免疫  基因疗法  人工智能  新药审批  
收稿时间:2017-12-20

Hot topics in drug research and development in 2017: Biological drug rapid growth,breakthrough therapy certification
LI Ziyan,HUANG Yaoqing,ZHOU Yinghong,MAO Yanyan,GAO Liubin.Hot topics in drug research and development in 2017: Biological drug rapid growth,breakthrough therapy certification[J].Science & Technology Review,2018,36(1):116-125.
Authors:LI Ziyan  HUANG Yaoqing  ZHOU Yinghong  MAO Yanyan  GAO Liubin
Institution:Information Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
Abstract:Drug R&D focus on breakthroughs and new progress in the field of life science and biotechnology. At present, drug R&D related disciplines become increasingly intersecting, new methods and technologies emerge rapidly, constantly improving the efficiency of drug R&D and innovating the way of disease treatment. From the perspective of new drugs approved by FDA in 2017, with the biotech drugs developing fast and the breakthrough therapy certification promoting drug innovation, unmet needs in the clinic are turning into the pursuit of the industry. This paper reviews the breakthrough progress and research hot topics in the field of drug R&D in 2017, exhibiting the direction and new trends to people in this field.
Keywords:R&D  immune-oncology  gene therapy  artificial intelligence  new drug approval  
点击此处可从《科技导报(北京)》浏览原始摘要信息
点击此处可从《科技导报(北京)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号